Two new indications for Gaviscon

The licence for Gaviscon Advance (sodium alginate, potassium bicarbonate) aniseed suspension has been extended.

It can now be used to treat of symptoms of gastro-oesophageal reflux during concomitant treatment with acid suppressing therapy and symptoms of laryngopharyngeal reflux.

View Gaviscon Advance drug record

Further information: Reckitt Benckiser

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases